104 related articles for article (PubMed ID: 748978)
1. Serum relaxin levels in prostaglandin E2 induced abortions.
Quagliarello J; Cederqvist L; Steinetz B; Weiss G
Prostaglandins; 1978 Dec; 16(6):1003-6. PubMed ID: 748978
[TBL] [Abstract][Full Text] [Related]
2. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
3. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
4. Serum relaxin concentrations in women following the administration of 16,16-dimethyl-trans-delta 2-PGE1 methyl ester during early pregnancy.
Seki K; Uesato T; Kato K
Prostaglandins; 1987 May; 33(5):739-42. PubMed ID: 3035621
[TBL] [Abstract][Full Text] [Related]
5. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
Lauersen NH; Secher NJ; Wilson KH
Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
7. New prostaglandin E2 analogue for pregnancy termination.
Bygdeman M; Gréen K; Bergström S; Bundy G; Kimball F
Lancet; 1979 May; 1(8126):1136. PubMed ID: 86850
[No Abstract] [Full Text] [Related]
8. Prostaglandin E2 induction of abortion and fetal demise.
Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
[TBL] [Abstract][Full Text] [Related]
9. Serum relaxin and steroid hormones in spontaneous abortions.
Seki K; Uesato T; Tabei T; Kato K
Acta Obstet Gynecol Scand; 1988; 67(6):483-6. PubMed ID: 3239380
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum hormone changes during abortion induced with 9-deoxo-16, 16-dimethyl-9-methylene prostaglandin E2.
Bremme K; Eneroth P; Bygdeman M
J Endocrinol Invest; 1982; 5(6):387-91. PubMed ID: 7169514
[TBL] [Abstract][Full Text] [Related]
11. Serial relaxin concentrations in human pregnancy.
Quagliarello J; Szlachter N; Steinetz BG; Goldsmith LT; Weiss G
Am J Obstet Gynecol; 1979 Sep; 135(1):43-4. PubMed ID: 474660
[TBL] [Abstract][Full Text] [Related]
12. The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2.
Cameron IT; Baird DT
Br J Obstet Gynaecol; 1984 Nov; 91(11):1136-40. PubMed ID: 6594157
[TBL] [Abstract][Full Text] [Related]
13. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
[TBL] [Abstract][Full Text] [Related]
15. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
Robins J; Surrago EJ
J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
[TBL] [Abstract][Full Text] [Related]
16. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
Lebed JP; Rubin A; Millman AE
Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
[TBL] [Abstract][Full Text] [Related]
17. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
Corson SL; Bolognese RJ
J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
[TBL] [Abstract][Full Text] [Related]
18. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
[TBL] [Abstract][Full Text] [Related]
19. Detection of relaxin release by porcine luteal cells using a reverse hemolytic plaque assay: effect of prostaglandins E2 and F2 alpha, human chorionic gonadotropin, and oxytocin.
Taylor MJ; Clark CL
Biol Reprod; 1987 Sep; 37(2):377-84. PubMed ID: 3315014
[TBL] [Abstract][Full Text] [Related]
20. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
